Table of Contents Author Guidelines Submit a Manuscript
International Journal of Dentistry
Volume 2017 (2017), Article ID 5815493, 7 pages
Research Article

Low Survival Rates of Oral and Oropharyngeal Squamous Cell Carcinoma

1CESMAC University Center, Maceió, AL, Brazil
2Federal University of Alagoas, Maceió, AL, Brazil
3Federal University of Rio de Janeiro, Rio de Janeiro, RJ, Brazil
4State Secretary of Health (SESAU), Alagoas, Brazil
5Post-Graduate Program in Dentistry, Estácio de Sá University, Rio de Janeiro, RJ, Brazil

Correspondence should be addressed to Sonia Maria Soares Ferreira

Received 2 February 2017; Revised 3 April 2017; Accepted 27 April 2017; Published 30 May 2017

Academic Editor: Gilberto Sammartino

Copyright © 2017 Anna Carolina Omena Vasconcellos Le Campion et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Aim. To assess the epidemiological and clinical factors that influence the prognosis of oral and oropharyngeal squamous cell carcinoma (SCC). Methods. One hundred and twenty-one cases of oral and oropharyngeal SCC were selected. The survival curves for each variable were estimated using the Kaplan-Meier method. The Cox regression model was applied to assess the effect of the variables on survival. Results. Cancers at an advanced stage were observed in 103 patients (85.1%). Cancers on the tongue were more frequent (23.1%). The survival analysis was 59.9% in one year, 40.7% in two years, and 27.8% in 5 years. There was a significant low survival rate linked to alcohol intake (), advanced cancer staging (), and procedures without surgery (). When these variables were included in the Cox regression model only surgery procedures () demonstrated a significant effect on survival. Conclusion. The findings suggest that patients who underwent surgery had a greater survival rate compared with those that did not. The low survival rates and the high percentage of patients diagnosed at advanced stages demonstrate that oral and oropharyngeal cancer patients should receive more attention.